Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The METROPHOLYS Study Metronomic Cyclophosphamide vs Doxorubicin in Elderly Patients With Advanced Soft Tissue Sarcomas Randomized, Controlled Open Label Clinical Trial

NCT04656262 is registered in ClinicalTrials.gov with Istituto Oncologico Veneto IRCCS as lead sponsor.

NCT NCT04656262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04656262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The METROPHOLYS Study Metronomic Cyclophosphamide vs Doxorubicin in Elderly Patients With Advanced Soft Tissue Sarcomas Randomized, Controlled Open Label Clinical Trial
Lead sponsor
Istituto Oncologico Veneto IRCCS
Phase
Phase 3
Overall status
Terminated
Start date
September 10, 2018
Completion date
May 23, 2024
Enrollment
79 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

soft tissue sarcoma adult